tests | S-Cr (umol/L) | 86.30 ± 30.28 | 92.77 ± 50.21 | 0.033* |
| hsCRP (mg/L) | 1.54 ± 1.03 | 1.65 ± 1.15 | 0.508 |
Cardiac | CKMB (ng/mL) | 9.61 ± 22.79 | 11.70 ± 20.68 | 0.493 |
biomarkers | BNP (pg/mL) | 393.53 ± 1145 | 809.13 ± 1542 | 0.009* |
| MYO (ng/mL) | 99.20 ± 165.56 | 127.42 ± 156.85 | 0.318 |
| aTnI (ng/mL) | 0.30 ± 1.41 | 0.78 ± 3.25 | 0.001* |
Coronary | LM (%) | 17 (6.6%) | 9 (5.4%) | 0.590 |
Artery | LAD (%) | 190 (74.2%) | 128 (76.2%) | 0.647 |
Occlusion | LCX (%) | 101 (39.5%) | 75 (44.6%) | 0.289 |
| RCA (%) | 137 (53.5%) | 98 (58.3%) | 0.329 |
| Single Vessel (%) | 144 (56.2%) | 86 (51.2%) | 0.306 |
| Two Vessels (%) | 52 (20.3%) | 29 (17.3%) | 0.434 |
| Three Vessels (%) | 60 (23.4%) | 53 (31.5%) | 0.065 |
Medications | Aspirin (%) | 254 (99.2%) | 166 (98.8%) |
|
| Clopidogrel (%) | 136 (53.1%) | 92 (54.8%) |
|
| Ticagrelor (%) | 121 (47.3%) | 76 (45.2%) |
|
| Atorvastatin (%) | 91 (35.5%) | 61 (36.3%) |
|
| Rosuvastatin (%) | 165 (64.5%) | 107 (63.7%) |
|
| Metoprolol (%) | 209 (81.6%) | 136 (81%) |
|